The Synthesis Company of San Francisco Mountain Logo
A Recombinant Blood‐Stage Malaria Vaccine Reduces Plasmodium falciparum Density and Exerts Selective Pressure on Parasite Populations in a Phase 1–2b Trial in Papua New Guinea | doi.page